Stock Research: PolyNovo

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

PolyNovo

ASX:PNV AU000000PNV0
8
  • Value
    18
  • Growth
    25
  • Safety
    Safety
    9
  • Combined
    1
  • Sentiment
    66
  • 360° View
    360° View
    8
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

PolyNovo Limited is an Australia-based medical device company focused on advanced wound care, designing, developing, and manufacturing dermal regeneration solutions. Its main businesses include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX, used for managing various wounds. In the last fiscal year, the company had a market cap of $538 million, profits of $66 million, revenue of $70 million, and 254 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 8 (better than 8% compared with alternatives), overall professional sentiment and financial characteristics for the stock PolyNovo are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for PolyNovo. The consolidated Sentiment Rank has a good rank of 66, which means that professional investors are more optimistic about the stock than for 66% of alternative investment opportunities. But all other ranks are below average. The consolidated Value Rank has a rank of 9, which means that the share price of PolyNovo is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 25, meaning that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. This means that growth is lower than for 25% of competitors in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 18 which means that the company has a riskier financing structure than 82% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
ASX 200
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 7 6 3
Growth
25 56 97 45
Safety
Safety
18 15 12 4
Sentiment
66 57 51 41
360° View
360° View
8 15 23 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 49 55 55
Opinions Change
50 50 72 50
Pro Holdings
n/a 51 40 50
Market Pulse
72 64 53 38
Sentiment
66 57 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 7 6 3
Growth
25 56 97 45
Safety Safety
18 15 12 4
Combined
1 4 21 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 10 5 3
Price vs. Earnings (P/E)
22 11 9 5
Price vs. Book (P/B)
10 3 3 1
Dividend Yield
1 1 1 1
Value
9 7 6 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 91 96 100
Profit Growth
56 80 94 75
Capital Growth
1 1 98 1
Stock Returns
5 51 23 17
Growth
25 56 97 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 40 41 24
Refinancing
13 9 17 5
Liquidity
28 18 12 6
Safety Safety
18 15 12 4

Similar Stocks

Discover high‑ranked alternatives to PolyNovo and broaden your portfolio horizons.

Hoya

TSE:7741
Country: Japan
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Suncorp

ASX:SUN
Country: Australia
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.